Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mustang Bio Inc (NQ: MBIO ) 0.2401 +0.0101 (+4.39%) Streaming Delayed Price Updated: 9:52 AM EDT, Sep 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Mustang Bio Inc < Previous 1 2 3 4 Next > 12 Health Care Stocks Moving In Thursday's After-Market Session August 05, 2021 Gainers Sensus Healthcare (NASDAQ:SRTS) ... Via Benzinga Mustang Bio's Gene Therapy For Genetic Immunodeficiency Receives European PRIME Tag August 02, 2021 The European Medicines Agency has granted Priority Medicines designation to Mustang Bio Inc's (NASDAQ: MBIO) MB-107 for X-linked severe combined... Via Benzinga 8 Health Care Stocks Showing Unusual Options Activity In Today's Session June 11, 2021 This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away... Via Benzinga The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts June 11, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,... Via Benzinga Why Mustang Bio's Stock Is Trading Higher Today May 18, 2021 Mustang Bio (NASDAQ:MBIO) shares are trading hig... Via Benzinga Mustang Bio's CAR T Cell Therapy Achieves 93% ORR, 67% CR In Mid-Stage Leukemia Trial June 11, 2021 Mustang Bio Inc (NASDAQ: MBIO) has updated interim data from the ongoing Phase 1/2 trial evaluating MB-106 for high-risk B-cell non-Hodgkin lymphomas (B-NHL) and... Via Benzinga The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck June 07, 2021 Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,... Via Benzinga Exposures Product Safety Diversifying to Conquer: Fortress Biotech (FBIO) Partnering Expansion Driving Progress in Cancer Immunotherapy and Rare Disease Therapeutics June 03, 2021 The following article is sponsored by the clinical communications unit of Redington, Inc. The information contained in this article in no way represents investment advice or... Via Benzinga Why Mustang Bio Stock Galloped Higher Today May 18, 2021 The biotech announced a clinical update and an analyst initiated coverage on the stock. Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2021 May 18, 2021 Upgrades Janney Montgomery Scott upgraded the previous rating for Centerspace (NYSE:CSR) from Neutral to Buy. In the first quarter, Centerspace showed an EPS of $0.95,... Via Benzinga BTIG Sees 260% Upside In Mustang Bio With PT of $11; Early-Stage MB-101 Starts Dosing Brain Tumor Patients May 18, 2021 Mustang Bio Inc (NASDAQ: MBIO) and the City of Hope, an independent cancer research and treatment center, have dosed the first patient in Phase 1 trial ... Via Benzinga 11 Health Care Stocks Moving In Tuesday's Pre-Market Session May 18, 2021 Gainers Onconova Therapeutics (NASDAQ:ONTX) stock increased by 36.14% to $0.84. The company's market cap stands at $198.7 million. As per the press release, Q1... Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session May 17, 2021 Gainers Venus Concept (NASDAQ:VERO) share... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
